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D8 T lymphocytes are implicated in the initiation, progression, and perpetuation of the pathogenic process and cause tissue damage in several autoimmune diseases (1) (2) (3) (4) . However, the cellular and molecular mechanisms that enable potentially autoreactive CD8 T cells to be activated by weak autoantigens remain unclear. Lymphopenia and chronic inflammatory conditions are known to promote autoimmune diseases (5) (6) (7) (8) . Lymphopenia induces homeostatic expansion of CD8 T lymphocytes driven by IL-15 and IL-7 (9, 10). IL-21, a proinflammatory cytokine produced by NKT and Th17 cells (11, 12) , has been implicated in the homeostatic expansion of CD8 T cells in the NOD mouse model of type 1 autoimmune diabetes (T1D) (13) . Genetic ablation of the IL-21R chain IL-21Ra protected the NOD mouse from disease development, which was attributed to defective Th17 response and inefficient T cell infiltration of the pancreas (14, 15) .
IL-21 can synergize with IL-7 or IL-15 to stimulate Agindependent proliferation of naive CD8 T cells (16, 17) . We have shown that naive CD8 T cells exposed to IL-21 in the presence of IL-7 or IL-15 display increased Ag sensitivity with increased proliferation and effector functions (18) . We refer to the increased Ag responsiveness of cytokine-prestimulated CD8 T cells as "cytokine priming" (19) . In the current study, we investigated whether synergistic stimulation by homeostatic and inflammatory cytokines in vivo would lead to the triggering of autoreactive CD8 T cells by weak autoantigens. For this purpose, we used Socs1 2/2 mice lacking suppressor of cytokine signaling 1 (SOCS1) that are rescued from IFN-g-induced perinatal lethality (20, 21) . These mice display an enlarged T cell compartment with selective accumulation of CD8 T cells that display CD44 hi CD122 hi memory-like phenotype, resulting from deregulated homeostatic proliferation driven by IL-15 (22) (23) (24) . SOCS1 is strongly induced in CD8 T cells following stimulation with IL-7, IL-15, or IL-21 (17) . In vitro, SOCS1-deficient CD8 T cells show increased Agindependent proliferation stimulated by IL-15 in the presence of IL-21 (17) . A variety of innate immune stimuli induce the expression of IL-15 in macrophages and dendritic cells and IL-21 in NKT cells (12, 25) . SOCS1-deficient macrophages, dendritic cells, and NKT cells have been shown to respond strongly to agents that stimulate the innate immune response (26) (27) (28) (29) . Therefore, we hypothesized that, in SOCS1-deficient mice, increased responsiveness to synergistic stimulation by endogenous IL-15 and IL-21 might lower the TCR signaling threshold presumably via cytokine priming and trigger potentially autoreactive CD8 T cells.
To test the above hypothesis, we generated P14 TCR transgenic mice lacking SOCS1 (Socs1 2/2 P14 mice). CD8 T cells bearing the transgenic P14 TCR (P14 cells) recognize the gp33 peptide, spanning aas 33-41 of the glycoprotein (GP) Ag of lymphocytic choriomeningitis virus (LCMV), restricted by the MHC class I molecule H-2D b (30) . Transgenic mice expressing the LCMV GP Ag under the rat insulin promoter ([RIP]-GP mice) are widely used to study cellular mechanisms underlying the activation of autoreactive CD8 T cells (30) (31) (32) (33) (34) . We have chosen the RIP-GP/ P14 model of T1D because, unlike the RIP-mOVA/OT-I system, the P14 cells are "ignorant" of the transgenic LCMV GP because of the low-level expression of the Ag (23, 34) . Because of this ignorance, RIP-GP/P14 double-transgenic mice or RIP-GP mice with adoptively transferred P14 cells do not develop disease without LCMV infection or gp33 immunization with concomitant activation of dendritic cells or induction of an inflammatory response (31) (32) (33) . We have substituted peptide immunization with in vitro stimulation of P14 cells with gp33 prior to adoptive transfer to induce T1D in the RIP-GP mice. We reasoned that SOCS1-deficient P14 cells, exposed to the stimulatory cytokine milieu in vivo, would show increased TCR sensitivity that would allow them to recognize the limiting amounts of gp33 in the islets and cause diabetes without peptide immunization or prior in vitro stimulation by gp33. Contrary to this expectation, SOCS1-deficient P14 cells failed to induce diabetes even after peptide stimulation. We show that in the absence of SOCS1, cytokinedriven functional differentiation compromises the Ag-induced proliferation of CD8 T cells. However, these cells become pathogenic following lympohopenia-driven homeostatic expansion.
Materials and Methods

Mice Socs1
+/2 Ifng 2/2 mice (20), obtained from Dr. J. Ihle (St. Jude Children's Research Hospital, Memphis, TN), were backcrossed to Ifng 2/2 mice in C57BL/6 background (The Jackson Laboratory, Bar Harbor, ME) for .10 generations in our animal facility. RIP-GP and P14 TCR transgenic mice (30) were bred in our animal facility to generate RIP-GP/P14 mice. Ifngra 2/2 and Rag1 2/2 mice in C57BL/6 background and pmel-1 TCR transgenic mice (35) were purchased from The Jackson Laboratory. Socs1
2/2 pmel-1, and Rag1 2/2 RIP-GP mice were generated in our animal facility. All experiments were carried out with the approval of institutional ethical committee.
Abs and reagents
Abs against mouse CD4, CD8, CD16/CD32, CD25, CD44, CD62L, CD122, TCR va2 (recognizes the P14 TCR), Ly6C, CD28, OX-40, 4-1BB, GITR, CTLA-4, and programmed death-1 conjugated to FITC, PE, or biotin were purchased from BD Pharmingen Biosciences (Palo Alto, CA) or eBioscience (San Diego, CA). Streptavidin-spectral red was from Southern Biotechnology Associates (Birmingham, AL). Recombinant cytokines IL-2, IL-7, IL-15, and IL-21 were purchased from R&D Systems (Minneapolis, MN). Polyinosinic:polycytidylic acid [poly(I:C)] was obtained from InvivoGen (San Diego, CA). RPMI 1640 cell culture medium and FBS were from Sigma-Aldrich (Oakville, Ontario, Canada). CFSE was purchased from Molecular Probes (Eugene, OR). Antigenic peptides were custom synthesized to .95% purity by GenScript (Scotch Plains, NJ).
Flow cytometry and magnetic cell sorting
Single-cell suspensions in PBS containing 5% FBS and 0.05% sodium azide were preincubated with anti-CD16/CD32 Ab for 10 min to block FcRs. Expression of cell surface markers was estimated by standard two-or threecolor staining using FITC-, PE-, and biotin-conjugated primary Abs, followed by streptavidin-spectral red. Data acquisition and analysis were done on a FACSCalibur using CellQuest software (BD Biosciences, San Jose, CA). CD8 + T cells were purified using Dynal mouse CD8 negative isolation kit (Invitrogen, Carlsbad, CA) following the manufacturer's instructions to 95-98% purity (18) .
Induction of T1D
A total of 5 3 10 6 unstimulated or 3 3 10 6 peptide-stimulated P14 cells were injected i.v. via the tail vein of RIP-GP or Rag1 2/2 RIP-GP recipients along with 200 mg poly(I:C), unless indicated otherwise. Blood glucose levels were monitored using Accu-Check strips (Roche Diagnostic Systems, Somerville, NJ). Animals that showed .15 mM glucose consecutively for 3 d were considered diabetic. At sacrifice, pancreatic tissues were frozen in Tissue-Tek OCT for immunohistochemistry. Animals that did not develop diabetes were sacrificed 4 wk after adoptive cell transfer. 
Cell proliferation
Homeostatic proliferation
Total splenocytes from mice of the indicated genotypes were labeled with CFSE as described elsewhere (24) , and 10 3 10 6 cells in 200 ml PBS were injected i.v. into 6-to 8-wk-old Rag1 2/2 mice. After 5 d, LN cells from the recipients were stained for CD8, and homeostatic proliferation was examined by dilution of CFSE within the CD8 gate. 
LCMV infection
ELISA
The amounts of IFN-g and IL-2 in the culture supernatants were determined by sandwich ELISA using Ab pairs purchased from BD Pharmingen Biosciences (Palo Alto, CA).
CTL assay
were prepared by incubation with 400 mCi/ml 51 Cr (NEN Life Sciences, Boston, MA) and the stimulatory gp33 (KAVYNFATM) or nonstimulatory AV (SGPSNTPPEI) peptide for 2 h at 37˚C. These target cells were washed and plated in 96-well roundbottomed microtiter plates with the indicated effector P14 cells at different E:T cell ratios. After incubation for 7 h at 37˚C, 100 ml supernatant was counted in a gamma counter (PerkinElmer). Specific lysis was calculated as detailed previously (18) .
Histopathology
Serial 5-mm cryosections of the frozen pancreatic tissues were stained with H&E or subjected to immunohistochemical staining. The sections were incubated with Abs against insulin (Abcam, Cambridge, MA), followed by HRP-conjugated secondary Abs. Diaminobenzamidine was used as substrate chromogen to reveal damage to b cells in the islets.
Statistical analysis
The p values were determined by Student t test. (Fig. 1A) . However, the frequency of CD8 + cells in the peripheral lymph nodes was comparable between SOCS1-deficient and control mice (Fig. 1B) . Even though lymph nodes in SOCS1-deficient P14 mice harbored slightly more CD8 + cells bearing the transgenic TCR Va2 TCR than in control mice, this difference was not statistically significant (Fig. 1C ). We and others have shown that CD8 + T cells in SOCS1-deficient mice bearing a polyclonal TCR repertoire expressed higher levels of the memory cell markers CD44, CD122, and Ly6C, without downmodulating the activation marker CD62L (22, 38) , a phenotype typical of memory-like cells arising from cytokine-driven homeostatic proliferation (39) . Likewise, P14 cells isolated from the lymph nodes of Socs1 2/2 P14 cells displayed a memory-like phenotype (Fig. 1D) . Consistent with the reports that SOCS1 is a critical regulator of IL-15 signaling in CD8 + T cells (17, 22, 38) , Socs1 2/2 P14 cells showed increased proliferation in response to IL-15, which was further augmented by IL-21 (Fig. 1E) . www.jimmunol.org
Results
SOCS1-deficient P14 cells fail to induce diabetes in RIP-GP mice
Downloaded from
Like Socs1 2/2 mice bearing a polyclonal TCR repertoire (20, 21) , Socs1 2/2 P14 mice became sick by 3 wk of age and died within 4 wk after birth, which was prevented by ablation of the Ifng gene. We generated Socs1 2/2 Ifng 2/2 RIP-GP/P14 mice to determine whether SOCS1 deficiency would overcome the "ignorance" of P14 cells as a consequence of increased cytokine stimulation and enable them to recognize the LCMV GP Ag expressed at a low level in the islets. P14 cells from Socs1 2/2 Ifng 2/2 RIP-GP/P14 mice also showed a memory-like phenotype and increased cytokineinduced proliferation (data not shown) but did not cause diabetes. These results indicated that increased cytokine stimulation as a result of SOCS1 deficiency was not sufficient to overcome the requirement for IFN-g to induce disease in the RIP-GP model, although IFN-g is dispensable in the NOD mouse model (40, 41) .
To circumvent this limitation, we adoptively transferred Socs1
P14 cells harboring the wild-type Ifng gene into RIP-GP recipients.
Adoptively transferred P14 cells cause diabetes in RIP-GP mice following immunization with gp33 peptide and concomitant administration of poly(I:C) to induce inflammation (30, 31, 33) . Instead of peptide immunization, we stimulated P14 cells with gp33 for 2 d in vitro and adoptively transferred these cells to RIP-GP mice with concomitant administration of poly(I:C). This method rapidly induced diabetes in all RIP-GP recipients within 5 d ( Fig. 2A (Fig. 3A) , and these cells failed to cause disease for up to 4 wk after adoptive transfer (Table I , group A4).
SOCS1 deficiency impairs Ag-induced proliferation of P14 cells
To test whether the inability of Socs1 2/2 P14 cells to cause diabetes in RIP-GP mice might have resulted from their impaired Ag responsiveness, we evaluated the proliferation of P14 cells from Socs1 2/2 and control P14 mice following TCR stimulation.
Compared with wild-type cells, Socs1 2/2 P14 cells displayed dramatically reduced proliferation to gp33 peptide ( Fig. 3B ) and negligible response to anti-CD3/CD28 beads (Fig. 3C) . These results showed that SOCS1 deficiency selectively impaired the proliferation of P14 cells in response to TCR stimulation, even though these cells proliferated robustly in response to cytokine stimulation (Fig. 3A) . P14 cells from Socs1 2/2 Ifng 2/2 mice also showed significantly reduced proliferation in response to gp33 (Fig. 3D) , suggesting that the impaired TCR responsiveness of SOCS1-deficient P14 cells was not secondary to the inflammatory milieu caused by deregulated IFN-g signaling in Socs1 6 cells), were injected into T cell-replete or lymphopenic RIP-GP recipients. All mice received 200 mg poly(I:C) i.v. at the time of cell transfer, except in one experiment (C4), as indicated. The recipient mice were followed for the onset of diabetes by testing the blood glucose level twice a week for up to 4 wk. Animals that showed .15 mM blood glucose were tested consecutively for 3 d before euthanasia. Mean 6 SD of disease onset is given. Total number of animals for each data set was pooled from two to six independent experiments. n.a., not applicable. (Fig. 5C ). We also observed that IL-15, but not IL-7, was able to substitute for IL-2 in reversing the Agspecific proliferation defect in Socs1 2/2 P14 cells (Fig. 5C ). These results demonstrate that SOCS1 deficiency compromises the ability of P14 cells to produce IL-2 following TCR stimulation and impairs their proliferation, a defect that can be reversed by exogenous IL-2 or IL-15. The Ag-specific proliferation defect of SOCS1-deficient P14 cells to TCR stimulation did not result from the lack of costimulatory receptors (CD28, OX40, GITR, and 4-1BB) or from the induction of inhibitory receptors (CTLA-4 and programmed death-1) (44-46) (Fig. 5D) . However, upregulation of these costimulatory and inhibitory receptors following Ag stimulation was impaired to variable extent in Socs1 2/2 P14 cells, presumably as a consequence of defective Ag responsiveness.
SOCS1-deficiency compromises Ag-induced proliferation of CD8 T cells independently of the TCR specificity
The above experiments suggested that naive CD8 T cells require SOCS1 to preserve their ability to proliferate in response to cognate Ags, which was supported by our observation on CD8 T cells with a different TCR specificity. Socs1 2/2 CD8 T cells expressing the pmel-1 transgenic TCR specific to the melanoma-specific gp100 Ag (35) also showed defective proliferation to peptide stimulation despite showing robust cytokine-induced proliferation (Fig. 6A) . By comparing the proliferation of adoptively transferred CD8 T cells in congenitally T cell-deficient mice raised in conventional or germ-free facility, Kieper et al. (47, 48) defined two types of homeostatic proliferation. Whereas proliferation driven by self-Ags and homeostatic cytokines occurred slowly in both recipients, only the congenitally T cell-deficient mice raised in conventional facility supported a faster rate of proliferation. The faster homeostatic proliferation was presumably driven by gut-derived Ags, which were absent in germ-free animals. To determine how SOCS1 deficiency influenced the Ag-dependent homeostatic proliferation in vivo, we labeled P14 cells from Socs1 2/2 or control mice with CFSE and adoptively transferred the cells to Rag1 2/2 RIP-GP recipients. Five days after transfer, we evaluated homeostatic proliferation of Socs1 2/2 and control P14 cells in mesenteric or pooled inguinal and brachial lymph nodes of Rag1 2/2 RIP-GP mice. We observed that the Ag-driven rapid homeostatic proliferation was severely impaired in Socs1 2/2 P14 cells (Fig. 6B , peaks on the left side of the dotted line). In contrast, these cells displayed strong cytokine-dependent homeostatic proliferation compared with control cells in inguinal and brachial lymph nodes, although this increase was less pronounced in mesenteric lymph nodes (Fig. 6B , peaks on the right side of the dotted line). These results showed that SOCS1 deficiency compromised the proliferation of CD8 T cells induced by cross-reactive foreign Ags in vivo. To examine whether SOCS1 was also needed to preserve the Aginduced proliferation of CD8 T cells with a polyclonal TCR specificity, we infected Socs1 2/2 Ifng 2/2 mice and the control animals with LCMV and evaluated the expansion of the CD8 T cell pool after 6 and 8 d. In C57BL/6 and Ifng 2/2 control mice, LCMV infection elicited a 3-fold increase in expansion of the CD8 T cell compartment with a negligible change in the CD4 compartment on day 8 following infection (Fig. 6C) . In contrast, the frequency of CD8 T cells decreased in Socs1 2/2 Ifng 2/2 mice following LCMV infection, and this decrease was not due to accelerated kinetics of expansion (Fig. 6C ). In agreement with the requirement for IFN-g signaling for efficient expansion of CD8 T cells following LCMV infection (49) 6C ). Taken together, the above results demonstrate that SOCS1 is essential to sustain the proliferative capacity of CD8 T cells following Ag stimulation.
SOCS1 deficiency enhances the Ag-specific effector functions of P14 cells
In a previous report, Davey et al. (23) have shown that SOCS1-deficient OVA-specific OT-I TCR transgenic CD8 T cells induced diabetes rapidly and more efficiently than wild-type OT-I cells in RIP-mOVA recipients, which express OVA in a membrane-bound form in pancreatic b cells. Even though proliferation of Socs1
OT-I T cells in response to OVA was not evaluated in this study, evidently Socs1 2/2 OT-I T cells had mounted potent Ag-specific cytolytic activity against the pancreatic islets. Therefore, we examined whether gp33 stimulation elicited effector functions in Socs1 2/2 P14 T cells.
Following Ag stimulation, Socs1 2/2 P14 cells produced significantly more IFN-g than SOCS1-expressing cells (Fig. 7A) . Even more strikingly, Socs1 2/2 P14 cells efficiently lysed the gp33-pulsed targets even without TCR stimulation (Fig. 7B) . The spontaneous lytic activity of Socs1 2/2 P14 cells was not a result of nonspecific CTL activity because they failed to kill target cells pulsed with the nonagonist AV peptide. Prior exposure to IL-15 and IL-21 induced the Ag-specific cytolytic activity in wild-type P14 cells, which was further augmented by SOCS1 deficiency, resulting in markedly enhanced cytolytic activity (Fig.  7C, left panel) . Subsequent Ag stimulation with a suboptimal concentration of gp33 peptide further enhanced the Ag-specific CTL activity of cytokine-primed Socs1 2/2 P14 cells (Fig. 7C,   right panel) . These results demonstrated that SOCS1-deficient P14 cells, despite their inability to proliferate, deployed potent effector functions upon Ag stimulation.
Homeostatic expansion of SOCS1-deficient P14 cells in RIP-GP mice induces diabetes
Induction of strong effector functions in SOCS1-deficient P14 cells following Ag stimulation suggested that the inability of these cells to induce diabetes in RIP-GP recipients could be attributed to their impaired proliferative capacity. Therefore, we tested whether the diabetogenic potential of SOCS1-deficient cells could be elicited if their proliferative defect was overcome by exogenous IL-2. Socs1 2/2 P14 cells expanded in vitro by gp33 in the presence of IL-2 readily induced disease with the same efficiency as wild-type P14 cells stimulated with gp33 (Fig. 2C , Table I , group B1). The above results indicated that SOCS1-deficient P14 cells retained their functional capacity to respond to Ag but must undergo expansion to cause overt disease. However, Socs1 2/2 P14 cells stimulated in vitro with IL-15 and IL-21 alone did not induce diabetes in RIP-GP recipients (Table I, group B2) . Next, we used Rag1 2/2 RIP-GP recipients to examine whether greater homeostatic expansion of Socs1 2/2 P14 cells induced by endogenous IL-15 in vivo (23, 24) would elicit their diabetogenic potential. Following adoptive transfer to Rag1 2/2 RIP-GP recipients, Socs1 2/2 P14 cells induced diabetes in all animals, albeit the disease onset was delayed to 3 wk (Fig. 2D , Table I , group C1). These results suggested that even though cytokine stimulation induced strong proliferation of (Fig. 2E , Table I , group C2), unless the donor cells were prestimulated with gp33 (Table I , group C3). These results suggested that the propensity of SOCS1-deficient P14 cells to develop effector functions upon cytokine stimulation was important to elicit their pathogenic potential. Surprisingly, T1D caused by homeostatic proliferation of Socs1 2/2 P14 cells in Rag1 2/2 RIP-GP mice did not require poly(I:C) ( Table I , group C4), suggesting that the homeostatically expanded Socs1 2/2 P14 cells behaved like Agstimulated P14 cells following LCMV infection in their ability to cause T1D in lymphopenic recipients (30) . These results showed that cytokine-driven homeostatic proliferation facilitates the expansion of Socs1 2/2 P14 cells in vivo and that these cells become cytolytic upon recognition of the gp33 Ag in the pancreatic b cells, leading to islet destruction. LCMV infection of RIP-GP mice bearing a polyclonal T cell repertoire can activate gp33-specific CD8 T cells, resulting in islet destruction and induction of diabetes (30) . The inefficient expansion of SOCS1-deficient CD8 T cells following LCMV infection (Fig.  6C) raised the possibility that SOCS1 deficiency would impair the LCMV-induced activation of gp33-specific CD8 T cells from a polyclonal repertoire. However, this issue was difficult to address directly because Socs1 2/2 RIP-GP mice failed to survive for .2 wk. Activation of SOCS1 knockout cells adoptively transferred to RIP-GP mice by LCMV infection or peptide immunization would be confounded by competition from gp33-specific CD8 cells of the recipient mice. Generating a bone marrow chimera with SOCS1-null cells in RIP-GP mice would lead to homeostatic expansion of SOCS1-deficient CD8 T cells leading to associated systemic pathology. Therefore, we addressed this issue indirectly following a published method (30) . We infected Socs1
mice bearing wild-type Ifng gene with LCMV to activate gp33-specific CD8 T cells from the polyclonal repertoire. One week postinfection, we adoptively transferred total splenocytes from these mice to Rag1 2/2 RIP-GP recipients. All the recipient mice developed diabetes (n = 5 from two experiments). This experiment indicated that even though CD8 T cells in SOCS1 knockout mice failed to undergo robust expansion following LCMV infection (Fig. 6C ), gp33-specific cells were activated and presumably expanded to a limited extent, which, upon homeostatic expansion in Rag1 2/2 RIP-GP recipients, caused disease.
Discussion
In this study, we demonstrate that SOCS1 prevents the activation of potentially autoreactive CD8 T cells primarily by controlling the Ag-independent, cytokine-driven proliferation, and functional differentiation into effector cells. Our findings also demonstrate a nonredundant function for SOCS1 in preserving the ability of naive CD8 T cells to proliferate in response to Ag stimulation. Although several studies have addressed the cytokine responses of SOCS1-deficient CD8 T cells in vitro and in vivo (17, (22) (23) (24) , few studies have examined their response to Ags. Davey et al. (23) attributed the increased diabetogenic potential of Socs1 IL-15 and IL-21 for 36 h, and the CD8 cells were purified to test CTL activity against gp33-loaded EL4 targets (left panel). In the right panel, the cytokine-treated cells were stimulated with 10 ng/ml gp33 peptide in the presence of irradiated C57BL/6 splenocytes for 36 h and equalized for the number of P14 cells before the CTL assay. In both instances, nonspecific lysis of AV peptide-loaded EL4 targets was negligible (data not shown). Data shown in B and C are representative of at least three independent experiments, containing a total of five to six mice in each group.
in RIP-GP mice as efficiently as SOCS1-sufficient P14 cells. 4B) . These results suggested that the signal rewiring, which was proposed to occur upon reversal of AINR (54), did not occur in the absence of SOCS1. An intriguing question is, how does SOCS1 deficiency induce the Ag-specific proliferation defect in P14 cells? Although split anergy and AINR are induced by TCR signaling, the Ag-specific proliferation defect of Socs1 2/2 P14 cells occurs in the absence of cognate Ag. Nonetheless, although increased cytokineinduced proliferation is certainly an important factor, it is likely that basal level of TCR signaling stimulated by self-and environmental Ags might also have contributed to the Ag-specific proliferation defect of Socs1 2/2 P14 cells. This possibility is supported by the inability of Socs1 2/2 OT-I cells to undergo homeostatic proliferation in TAP1-deficient mice (23) . Potential contribution of cytokines, such as IL-7, IL-21, and IL-6, in autoimmune diseases has been well documented in mouse models (14, 15, 55, 56) . These homeostatic and inflammatory cytokines would be abundantly available during lymphopenia and inflammatory conditions. It has long been suggested that cytokine-driven homeostatic proliferation may favor expansion of autoreactive CD8 T cells (5, 6, 13, 57, 58) . Cytokine-driven bystander activation of autoreactive CD8 T cells may occur in normal animals during microbial infections and chronic inflammation, and this may also contribute to the triggering of potentially autoreactive CD8 T cells (59). Ehl et al. (60) have investigated the contribution of bystander activation of autoreactive CD8 T cells by infecting the RIP-GP/P14 TCR double-transgenic mice with vaccinia virus that does not express any cross-reactive Ags. Even though this study showed that bystander activation of P14 cells could lead to insulitis, the infected animals did not develop diabetes. A limitation of this experiment could be the competition for cytokine resources by T cells reactive to vaccinia Ags and the limited duration of activation compared with homeostatic proliferation. Even in the absence of T cells competing for foreign Ags in lymphopenic RIP-GP mice, SOCS1-deficent P14 cells required 3-4 wk to cause overt disease (Table I , group C). It is noteworthy that progression from insulitis to clinical diabetes takes 1-3 mo in the NOD mouse and in the BB-DP rat models of autoimmune diabetes (7, 61) . Hence, as the "fertile-field hypothesis of autoimmunity" (59) predicts, Ag nonspecific activation of autoreactive CD8 T cells by heterologous infectious agents, presumably via induction of the priming cytokines (19) , will require successive episodes of cytokine-driven expansion over a long period and escape from the peripheral tolerance mechanisms before the manifestation of clinical disease.
The two functions of SOCS1 in CD8 T cells described in this paper, namely prevention of Ag-independent cytokine-driven functional differentiation and preservation of Ag-induced proliferation, have important implications for the higher incidence of autoimmunity as well as impaired immune response to infectious agents during aging. For instance, accumulation of oligoclonal CD8 T cell population in aged mice and humans, which arises from cytokine-driven expansion (62) , may also be associated with their functional differentiation that might underlie the higher incidence of autoimmune disorders and less efficient immune responses toward pathogens upon aging (63, 64) . It is noteworthy that the Socs1 gene is highly susceptible to epigenetic repression by CpG methylation (65) and regulation by microRNA (66) . Further studies will determine whether these regulatory processes that suppress the expression of the Socs1 gene are amplified in CD8 T cells that accumulate in aged mice and humans.
